Log in to save to my catalogue

Simultaneous Subconjunctival Triamcinolone and Bevacizumab Injections for Management of Blepharokera...

Simultaneous Subconjunctival Triamcinolone and Bevacizumab Injections for Management of Blepharokera...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a24a9bc03aac42b3a6f0e6090d542add

Simultaneous Subconjunctival Triamcinolone and Bevacizumab Injections for Management of Blepharokeratoconjunctivitis in Children

About this item

Full title

Simultaneous Subconjunctival Triamcinolone and Bevacizumab Injections for Management of Blepharokeratoconjunctivitis in Children

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

Journal title

Case reports in ophthalmological medicine, 2018-01, Vol.2018 (2018), p.1-4

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

More information

Scope and Contents

Contents

Purpose. To report the efficacy of subconjunctival triamcinolone (Kenalog A-40, Alcon) and bevacizumab (Avastin, Genentech) injections in fraternal twins with blepharokeratoconjunctivitis (BKC) causing progressive, bilateral corneal neovascularization and scarring. Methods. In this retrospective observational case series, two three-year-old male tw...

Alternative Titles

Full title

Simultaneous Subconjunctival Triamcinolone and Bevacizumab Injections for Management of Blepharokeratoconjunctivitis in Children

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a24a9bc03aac42b3a6f0e6090d542add

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a24a9bc03aac42b3a6f0e6090d542add

Other Identifiers

ISSN

2090-6722

E-ISSN

2090-6730

DOI

10.1155/2018/2602487

How to access this item